These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31405314)

  • 1. The multiple roles of exosomes in Parkinson's disease: an overview.
    Porro C; Panaro MA; Lofrumento DD; Hasalla E; Trotta T
    Immunopharmacol Immunotoxicol; 2019 Aug; 41(4):469-476. PubMed ID: 31405314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
    Chistiakov DA; Chistiakov AA
    Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers.
    Zhao Y; Yang G
    Neurochem Int; 2021 Mar; 144():104974. PubMed ID: 33485881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes from patients with Parkinson's disease are pathological in mice.
    Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T
    J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of α-Synuclein in Exosomes.
    Tsunemi T; Ishiguro Y; Yoroisaka A; Hattori N
    Methods Mol Biol; 2021; 2322():41-45. PubMed ID: 34043190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.
    Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A
    Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia.
    Dai M; Yan L; Yu H; Chen C; Xie Y
    J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial-Derived Vesicles as Candidate Biomarkers in Parkinson's Disease: Rationale, Design and Methods of the EXosomes in PArkiNson Disease (EXPAND) Study.
    Picca A; Guerra F; Calvani R; Bucci C; Lo Monaco MR; Bentivoglio AR; Landi F; Bernabei R; Marzetti E
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia as modulators of exosomal alpha-synuclein transmission.
    Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
    Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
    Chang C; Lang H; Geng N; Wang J; Li N; Wang X
    Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes in Parkinson disease.
    Pinnell JR; Cui M; Tieu K
    J Neurochem; 2021 May; 157(3):413-428. PubMed ID: 33372290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles and Neurodegenerative Diseases.
    Hill AF
    J Neurosci; 2019 Nov; 39(47):9269-9273. PubMed ID: 31748282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease Derived Exosomes Aggravate Neuropathology in SNCA*A53T Mice.
    Huang Y; Liu Z; Li N; Tian C; Yang H; Huo Y; Li Y; Zhang J; Yu Z
    Ann Neurol; 2022 Aug; 92(2):230-245. PubMed ID: 35596947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy.
    Izco M; Carlos E; Alvarez-Erviti L
    Neuroscientist; 2022 Apr; 28(2):180-193. PubMed ID: 33530851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson's Disease.
    Tofaris GK
    J Parkinsons Dis; 2017; 7(4):569-576. PubMed ID: 28922170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges.
    Dutta S; Hornung S; Taha HB; Bitan G
    Acta Neuropathol; 2023 May; 145(5):515-540. PubMed ID: 37012443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
    Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.